Paragon 28, Inc. (NYSE:FNA – Get Free Report) has earned a consensus rating of “Hold” from the six ratings firms that are presently covering the company, Ratings reports. Four research analysts have ...

A plaque is to be installed at Hull railway station to remember the victims of a rail crash nearly a century ago. Twelve people were killed and 46 injured when two trains crashed head-on just outside ...

Fintel reports that on January 30, 2025, Stephens & Co. downgraded their outlook for Paragon 28 (NYSE:FNA) from Overweight to ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $13.4, a ...

William Blair has recently reduced Paragon 28 Inc (FNA) stock to Mkt Perform rating, as announced on Today, according to Finviz. Earlier, on Today, Needham had reduced the stock from a Buy to Hold.

Fintel reports that on January 29, 2025, Needham downgraded their outlook for Paragon 28 (NYSE:FNA) from Buy to Hold. Analyst ...

Parents need to know that this sequel to the zombie horror fest 28 Days Later is at least as scary and disturbing as the original. Extreme, graphic peril and violence are nonstop; sympathetic ...

Zimmer Biomet Holdings Inc. plans to acquire a Colorado-based business with “an extensive suite of surgical offerings and product systems spanning all major foot and ankle segments.” ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Paragon 28, Inc. (NYSE: FNA) to Zimmer Biomet Holdings, Inc. for $13.00 per share in cash is fair to Paragon 28 ...

Paragon 28 has reported net revenue for the full year of 2024 in the range of $255.9 to $256.2 million, representing 18.2% to ...

Zimmer Biomet has entered into a definitive agreement to purchase Paragon 28, a medical device company focused exclusively on foot-and-ankle orthopedics.

Paragon 28 shares rose 8.4% after Zimmer Biomet Holdings agreed to acquire the company. Shares were trading around $13.02. The stock is up about 2.6% over the last year.